(MPW) Medical Properties Trust - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58463J3041
MPW EPS (Earnings per Share)
MPW Revenue
MPW: Hospital, Real Estate, Investments, Healthcare, Financing
Medical Properties Trust, Inc. is a self-advised real estate investment trust that has been a major player in the healthcare real estate sector since its inception in 2003. With a global footprint spanning nine countries and three continents, the company has established itself as one of the largest owners of hospital facilities, boasting an impressive portfolio of 393 facilities and approximately 39,000 licensed beds as of March 31, 2025. MPTs business model is centered around providing financing solutions that enable hospital operators to unlock the value of their real estate assets, thereby facilitating facility upgrades, technology investments, and operational improvements.
As a Health Care REIT, Medical Properties Trusts financial performance is closely tied to the overall healthcare landscape, including trends in hospital utilization, reimbursement rates, and regulatory policies. The companys ability to generate stable cash flows is dependent on its ability to secure long-term leases with creditworthy tenants, as well as its capacity to adapt to changing market conditions. With a diverse portfolio of properties and a global presence, MPT is well-positioned to capitalize on emerging trends in the healthcare sector.
Analyzing the technical data, we observe that MPWs stock price has been trending downward, with the last price of $4.49 being below its SMA20 and SMA50. The ATR indicates a relatively high volatility of 3.95%. Considering the fundamental data, the companys market capitalization stands at $2.72 billion, with a forward P/E ratio of 6.67, suggesting a relatively low valuation. However, the negative RoE of -30.80% raises concerns about the companys profitability. Based on these inputs, our forecast suggests that MPWs stock price may continue to face downward pressure in the short term, potentially testing the 52W low of $3.67. Nevertheless, if the company can demonstrate improved profitability and stabilize its cash flows, we may see a rebound in the stock price, potentially targeting the SMA200 at $4.83.
Looking ahead, Medical Properties Trusts ability to navigate the complex healthcare landscape and adapt to changing market conditions will be crucial in determining its future success. As the company continues to execute on its business strategy, investors will be closely watching for signs of improved profitability and cash flow stability. Our analysis suggests that MPWs stock price may present a buying opportunity for investors with a long-term horizon, provided that the company can demonstrate a clear path to profitability and sustainable cash flows.
Additional Sources for MPW Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
MPW Stock Overview
Market Cap in USD | 2,656m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 2005-07-08 |
MPW Stock Ratings
Growth Rating | -57.5 |
Fundamental | -44.0 |
Dividend Rating | 26.3 |
Rel. Strength | -12.4 |
Analysts | 2.73 of 5 |
Fair Price Momentum | 3.84 USD |
Fair Price DCF | 3.95 USD |
MPW Dividends
Dividend Yield 12m | 7.16% |
Yield on Cost 5y | 2.52% |
Annual Growth 5y | -15.69% |
Payout Consistency | 93.8% |
Payout Ratio | % |
MPW Growth Ratios
Growth Correlation 3m | -92.1% |
Growth Correlation 12m | 31.1% |
Growth Correlation 5y | -83.5% |
CAGR 5y | -18.97% |
CAGR/Max DD 5y | -0.22 |
Sharpe Ratio 12m | -1.08 |
Alpha | -11.88 |
Beta | 1.106 |
Volatility | 43.21% |
Current Volume | 14296.5k |
Average Volume 20d | 7032.9k |
As of June 21, 2025, the stock is trading at USD 4.44 with a total of 14,296,466 shares traded.
Over the past week, the price has changed by +2.53%, over one month by -8.10%, over three months by -23.88% and over the past year by -1.24%.
Probably not. Based on ValueRay´s Fundamental Analyses, Medical Properties Trust (NYSE:MPW) is currently (June 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -44.04 and therefor a somewhat negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MPW is around 3.84 USD . This means that MPW is currently overvalued and has a potential downside of -13.51%.
Medical Properties Trust has received a consensus analysts rating of 2.73. Therefor, it is recommend to hold MPW.
- Strong Buy: 0
- Buy: 2
- Hold: 5
- Sell: 3
- Strong Sell: 1
According to our own proprietary Forecast Model, MPW Medical Properties Trust will be worth about 4.2 in June 2026. The stock is currently trading at 4.44. This means that the stock has a potential downside of -6.53%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 5.2 | 17.3% |
Analysts Target Price | 5.5 | 23.9% |
ValueRay Target Price | 4.2 | -6.5% |